Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
Open accessAbstract
Selective blockers of the norepinephrine transporter (NET) inhibit dopamine uptake in the prefrontal cortex. This suggests that dopamine in this region is normally cleared by the somewhat promiscuous NET. We have tested this hypothesis by comparing the effects of inhibitors selective for the three monoamine transporters with those of a nonspecific inhibitor, cocaine, on uptake of 3H-dopamine into synaptosomes from frontal cortex, caudate nucleus, and nucleus accumbens from wild-type, NET, and dopamine transporter (DAT) knock-out mice. Dopamine uptake was inhibited by cocaine and nisoxetine, but not by GBR12909, in frontal cortex synaptosomes from wild-type or DAT knock-out mice. At transporter-specific concentrations, nisoxetine and GBR12909 failed to block dopamine uptake into frontal cortex synaptosomes from NET knock-out mice. The efficacy of cocaine at the highest dose (1 mm) was normal in DAT knock-out mice but reduced by 70% in NET knock-out mice. Nisoxetine inhibited dopamine uptake by 20% in caudate and nucleus accumbens synaptosomes from wild-type and DAT knock-out mice but had no effect in those from NET knock-out mice. Cocaine failed to block dopamine uptake into caudate or nucleus accumbens synaptosomes from DAT knock-out mice. Cocaine and GBR12909 each inhibited dopamine uptake into caudate synaptosomes from NET knock-out mice, but cocaine effectiveness was reduced in the case of nucleus accumbens synaptosomes. Thus, whereas dopamine uptake in caudate and nucleus accumbens depends primarily on the DAT, dopamine uptake in frontal cortex depends primarily on the NET. These data underscore the fact that which transporter clears dopamine from a given region depends on both the affinities and the local densities of the transporters.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In prefrontal cortex, norepinephrine transporters contribute to dopamine reuptake and mediate dopamine increases.
“Although prefrontal regions expresses low DAT levels (Sesack et al., 1998), MP also blocks norepinephrine transporters (Hannestad et al., 2010), which in prefrontal cortex contribute to DA reuptake and mediate DA increases (Carboni et al., 1990; Morón et al., 2002).”
From Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder (2012) · cites this paper as Morón et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · see citing works
On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine
Roberts, D. C. S., Corcoran, M. E., & Fibiger, H. C. (1977) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(77)90084-3 · Cited by 728 · see citing works
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626 · see citing works
Cloning of a Serotonin Transporter Affected by Antidepressants
Hoffman, B. J., Mezey, É., & Brownstein, M. (1991) · Science · doi:10.1126/science.1948036 · Cited by 614 · see citing works
The dopamine transporter: immunochemical characterization and localization in brain
Ciliax, B. J., Heilman, C. J., Demchyshyn, L. L., Pristupa, Z. B., Ince, E., Hersch, S. M., Niznik, H. B., & Levey, A. I. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01714.1995 · Cited by 589 · see citing works
Cocaine self-administration in dopamine-transporter knockout mice
Rocha, B. A. G., Fumagalli, F., Gainetdinov, R. R., Jones, S. R., Ator, R., Giros, B., Miller, G. W., & Caron, M. G. (1998) · Nature Neuroscience · doi:10.1038/381 · Cited by 519 · see citing works
Self-citationde Wit, H., & Wise, R. A. (1977) · Canadian Journal of Psychology / Revue canadienne de psychologie · doi:10.1037/h0081662 · Cited by 491 · see citing works
Self-citationSora, I., Hall, F. S., Andrews, A. M., Itokawa, M., Li, X.-F., Wei, H.-B., Wichems, C. H., Lesch, K., Murphy, D. L., & Uhl, G. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091039298 · Cited by 474 · see citing works
Ritz, M. C., Cone, E. J., & Kuhar, M. J. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90132-b · Cited by 469 · see citing works
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants
Xu, F., Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Bohn, L., Miller, G. W., Wang, Y.-M., & Caron, M. G. (2000) · Nature Neuroscience · doi:10.1038/74839 · Cited by 464 · see citing works
Garris, P., & Wightman, R. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00442.1994 · Cited by 413 · see citing works
Carboni, E., Tanda, G., Frau, R., & Chiara, G. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04599.x · Cited by 412 · see citing works
Gu, H., Wall, S. C., & Rudnick, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37256-3 · Cited by 379 · see citing works
Wu, X., Kekuda, R., Huang, W., Fei, Y.-J., Leibach, F. H., Chen, J., Conway, S. J., & Ganapathy, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32776 · Cited by 370 · see citing works
Busch, A. E., Karbach, U., Miska, D., Gorboulev, V., Akhoundova, A., Volk, C., Arndt, P., Ulzheimer, J. C., Sonders, M. S., Baumann, C., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.342 · Cited by 333 · see citing works
Bruno Giros, A., Wang, Y. M., Suter, S. E., McLeskey, S. B., Pifl, C., & Caron, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33961-3 · Cited by 322 · see citing works
Tanda, G., Carboni, E., Frau, R., & Chiara, G. D. (1994) · Psychopharmacology · doi:10.1007/bf02244785 · Cited by 320 · see citing works
Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter
Schroeter, S., Apparsundaram, S., Wiley, R. G., Miner, L. H., Sesack, S. R., & Blakely, R. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000501)420:2 · Cited by 277 · see citing works
Dopamine transporter immunoreactivity in rat brain
Freed, C. R., Revay, R. S., Vaughan, R. A., Kriek, E. H., Grant, S., Uhl, G. R., & Kuhar, M. J. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903590211 · Cited by 246 · see citing works
Nirenberg, M. J., Chan, J., Pohorille, A., Vaughan, R. A., Uhl, G. R., Kuhar, M. J., & Pickel, V. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-18-06899.1997 · Cited by 242 · see citing works
Eshleman, A. J., Carmolli, M., Cumbay, M. G., Martens, C. R., Neve, K. A., & Janowsky, A. J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38214-x · Cited by 219 · see citing works
Regulation of Extracellular Dopamine by the Norepinephrine Transporter
Yamamoto, B. K., & Novotney, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010274.x · Cited by 218 · see citing works
Raiteri, M., Carmine, R. D., Bertollini, A., & Levi, G. (1977) · European Journal of Pharmacology · doi:10.1016/0014-2999(77)90202-3 · Cited by 210 · see citing works
Moll, G. H., Mehnert, C., Wicker, M., Bock, N., Rothenberger, A., Rüther, E., & Huether, G. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00182-0 · Cited by 204 · see citing works
G�rard, C., Mestikawy, S. E., Lebrand, C., Adrien, J., Ruat, M., Traiffort, É., Hamon, M., & Martres, M. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199607)23:3 · Cited by 194 · see citing works
Habit-forming actions of nomifensine in nucleus accumbens
Carlezon, W. A., Devine, D. P., & Wise, R. A. (1995) · Psychopharmacology · doi:10.1007/bf02246095 · Cited by 170 · see citing works
Self-citationTanda, G., Pontieri, F. E., Frau, R., & Chiara, G. D. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01375.x · Cited by 169 · see citing works
Brown, P., & Molliver, M. E. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01952.2000 · Cited by 168 · see citing works
Transport of Monoamine Transmitters by the Organic Cation Transporter Type 2, OCT2
Gründemann, D., Koster, S. K., Kiefer, N., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30915 · Cited by 157 · see citing works
Cass, W. A., & Gerhardt, G. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010201.x · Cited by 144 · see citing works
Sakaue, M., Somboonthum, P., Nishihara, B., Kōyama, Y., Hashimoto, H., Baba, A., & Matsuda, T. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703139 · Cited by 143 · see citing works
Izenwasser, S., Werling, L. L., & Cox, B. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)91719-w · Cited by 128 · see citing works
Pozzi, L., Invernizzi, R. W., Cervo, L., Vallebuona, F., & SAMANIN, R. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63010195.x · Cited by 113 · see citing works
Horn, A. S. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08331.x · Cited by 109 · see citing works
Russ, H., Staudt, K., Martel, F., et al. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01294.x · Cited by 108 · see citing works
Cellular and subcellular localization of the dopamine transporter in rat cortex
Sesack, S. R., Hawrylak, V. A., Guido, M. A., & Levey, A. I. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60720-6 · Cited by 101 · see citing works
Protein kinase C activators decrease dopamine uptake into striatal synaptosomes.
Copeland, B. J., Vogelsberg, V., Neff, N. H., & Hadjiconstantinou, M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13104-2 · Cited by 97 · see citing works
Pozzi, L., Invernizzi, R. W., Garavaglia, C., & SAMANIN, R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731051.x · Cited by 86 · see citing works
Stamford, J. A., Kruk, Z. L., Palij, P., et al. (1988) · Brain Research · doi:10.1016/0006-8993(88)91282-6 · Cited by 82 · see citing works
Wang, Y.-M., Xu, F., Gainetdinov, R. R., & Caron, M. G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00245-0 · Cited by 82 · see citing works
Problems with currently available antidepressants.
Gumnick, J. F., & Nemeroff, C. B. (2000) · PubMed · Cited by 79 · see citing works
Izenwasser, S., Terry, P., Heller, B., et al. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90723-4 · Cited by 63 · see citing works
Matsumoto, M., Togashi, H., Mori, K., Ueno, K., Miyamoto, A., & Yoshioka, M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00636-6 · Cited by 62 · see citing works
Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers.
Chiara, G. D., Tanda, G., Frau, R., & Carboni, E. (1992) · PubMed · Cited by 53 · see citing works
Rho, M.-J., Cabana, T., & Drew, T. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971117)388:2 · Cited by 50 · see citing works
Brain noradrenaline and the mechanisms of action of antidepressant drugs
Svensson, T. (2000) · Acta Psychiatrica Scandinavica Supplementum · doi:10.1034/j.1600-0447.2000.02604.x · Cited by 47 · see citing works
Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?
Eriksson, E. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.00003.x · Cited by 38 · see citing works
Elsworth, J. D., TAYLOR, J., Berger, P. A., & Roth, R. A. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90144-t · Cited by 32 · see citing works
Wightman, R. M., & Garris, P. A. (2021) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/eprv-qp60 · Cited by 24 · see citing works
“In vitro” effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system
Morón, J., Pérez, V., FERNANDEZ‐ALVAREZ, E., et al. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6499-0_37 · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · see citing works
Self-citationSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020 · see citing works
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592 · see citing works
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073 · see citing works
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893 · see citing works
Modafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713 · see citing works
del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.036 · Cited by 685 · see citing works
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617 · see citing works
Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies
Tromp, D., Dufour, A., Lithfous, S., Pebayle, T., & Després, O. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.08.006 · Cited by 390 · see citing works
The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393 · see citing works
Development of prefrontal cortex
Kolk, S. M., & Rakic, P. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01137-9 · Cited by 378 · see citing works
“In addition, noradrenalin seems to have an effect on the development of dopaminergic projections in the PFC by providing a dopamine reuptake mechanism through the noradrenalin transporter [144, 145] as well as on GABAergic signaling in the PFC [146, 147].”
BackgroundPharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Kreek, M. J., Bart, G., Lilly, C., Laforge, K. S., & Nielsen, D. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.1 · Cited by 391 · see citing works
Catechol- <i>O</i> -Methyltransferase Genotype and Dopamine Regulation in the Human Brain
Akil, M., Kolachana, B. S., Rothmond, D. A., Hyde, T. M., Weinberger, D. R., & Kleinman, J. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02008.2003 · Cited by 325 · see citing works
Volkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Wong, C., Ding, Y.-S., Hitzemann, R., Swanson, J. M., & Kalivas, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0433-05.2005 · Cited by 304 · see citing works
The many faces of fatigue in major depressive disorder
Demyttenaere, K., De Fruyt, J., & Stahl, S. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004729 · Cited by 288 · see citing works
Bolea-Alamañac, B., Nutt, D. J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., Heal, D., Müller, U., Nash, J., Santosh, P., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113519509 · Cited by 287 · see citing works
Tolcapone improves cognition and cortical information processing in normal human subjects
Apud, J. A., Mattay, V., Chen, J., Kolachana, B. S., Callicott, J. H., Rasetti, R., Alce, G., Iudicello, J. E., Akbar, N., Egan, M. F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301227 · Cited by 242 · see citing works
Volkow, N. D., Wang, G.-J., Tomasi, D., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F. W., Fowler, J. S., Logan, J., Wong, C. T., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4461-11.2012 · Cited by 237 · see citing works
Hannestad, J., Gallezot, J.-D., Planeta-Wilson, B., Lin, S.-F., Williams, W. A., van Dyck, C. H., Malison, R. T., Carson, R. E., & Ding, Y.-S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.017 · Cited by 236 · see citing works
Mesocortical Dopamine Neurons Operate in Distinct Temporal Domains Using Multimodal Signaling
Lavin, A., Nogueira, L., Lapish, C. C., Wightman, R. M., Phillips, P. E. M., & Seamans, J. K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0557-05.2005 · Cited by 233 · see citing works
Prefrontal and monoaminergic contributions to stop-signal task performance in rats
Bari, A., Mar, A. C., Theobald, D. E., Elands, S. A., Oganya, K. C. N. A., Eagle, D. M., & Robbins, T. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1543-11.2011 · Cited by 188 · see citing works
Rubia, K., Halari, R., Cubillo, A., Smith, A. B., Mohammad, A.-M., Brammer, M., & Taylor, E. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.30 · Cited by 184 · see citing works
Paloyelis, Y., Asherson, P., Mehta, M. A., Faraone, S. V., & Kuntsi, J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.124 · Cited by 180 · see citing works
The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex
Spencer, R. C., Devilbiss, D. M., & Berridge, C. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.013 · Cited by 164 · see citing works
Herrera-Guzmán, I., Gudayol-Ferré, E., Herrera-Guzmán, D., Guàrdia-Olmos, J., Hinojosa-Calvo, E., & Herrera-Abarca, J. E. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.015 · Cited by 160 · see citing works
Dempster, E. L., Mill, J., Craig, I. W., & Collier, D. A. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-10 · Cited by 129 · see citing works
Herrera-Guzmán, I., Herrera-Abarca, J. E., Gudayol-Ferré, E., Herrera-Guzmán, D., Gómez-Carbajal, L., Peña-Olvira, M., Villuendas-González, E., & Joan, G.-O. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.006 · Cited by 120 · see citing works
Characterization of A11 neurons projecting to the spinal cord of mice
Koblinger, K., Füzesi, T., Ejdrygiewicz, J., Krajacic, A., Bains, J. S., & Whelan, P. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109636 · Cited by 114 · see citing works
Schulz, K. P., Fan, J., Bédard, A.-C. V., Clerkin, S. M., Ivanov, I., Tang, C. Y., Halperin, J. M., & Newcorn, J. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2053 · Cited by 114 · see citing works
Improving permeability and oral absorption of mangiferin by phospholipid complexation
Ma, H., Chen, H., Sun, L., Tong, L., & Zhang, T. (2014) · Fitoterapia · doi:10.1016/j.fitote.2013.10.016 · Cited by 108 · see citing works
Bari, A., & Robbins, T. W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3141-6 · Cited by 105 · see citing works
Locus Coeruleus and Dopamine-Dependent Memory Consolidation
Yamasaki, M., & Takeuchi, T. (2017) · Neural Plasticity · doi:10.1155/2017/8602690 · Cited by 91 · see citing works
Bailey, C. R., Cordell, E., Sobin, S. M., & Neumeister, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0051-4 · Cited by 89 · see citing works
Methylphenidate facilitates learning-induced amygdala plasticity
Tye, K. M., Tye, L. D., Cone, J. J., Hekkelman, E. F., Janak, P. H., & Bonci, A. (2010) · Nature Neuroscience · doi:10.1038/nn.2506 · Cited by 89 · see citing works
Winstanley, C. A., Zeeb, F. D., Bedard, A., Fu, K., Lai, B., Steele, C., & Wong, A. C. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.044 · Cited by 84 · see citing works
Harvey, R. C., Sen, S., Deaciuc, A., Dwoskin, L. P., & Kantak, K. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.223 · Cited by 86 · see citing works
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood
Nemoda, Z., Szekely, A., & Sasvari-Szekely, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.002 · Cited by 78 · see citing works
The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining
Gonon, F. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.010 · Cited by 79 · see citing works
Yamashita, M., Fukushima, S., Shen, H.-W., Hall, F. S., Uhl, G. R., Numachi, Y., Kobayashi, H., & Sora, I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301009 · Cited by 77 · see citing works
Herrera-Guzmán, I., Gudayol-Ferré, E., Lira-Mandujano, J., Herrera-Abarca, J., Herrera-Guzmán, D., Montoya-Pérez, K., & Guardia-Olmos, J. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.04.012 · Cited by 78 · see citing works
Norepinephrine, neurodevelopment and behavior
Saboory, E., Ghasemi, M., & Mehranfard, N. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104706 · Cited by 75 · see citing works
Wahlstrom, D., White, T., Hooper, C. J., Vrshek-Schallhorn, S., Oetting, W. S., Brott, M. J., & Luciana, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.045 · Cited by 66 · see citing works
Achterberg, E. J. M., van Kerkhof, L. W. M., Damsteegt, R., Trezza, V., & Vanderschuren, L. J. M. J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2945-14.2015 · Cited by 58 · see citing works
Gasser, P. J., Hurley, M. M., Chan, J., & Pickel, V. M. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1315-9 · Cited by 52 · see citing works
Sigurdardottir, H. L., Kranz, G. S., Rami‐Mark, C., James, G. M., Vanicek, T., Gryglewski, G., Kautzky, A., Hienert, M., Traub‐Weidinger, T., Mitterhauser, M., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23071 · Cited by 51 · see citing works
Jordan, C. J., Harvey, R. C., Baskin, B. B., Dwoskin, L. P., & Kantak, K. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.04.020 · Cited by 38 · see citing works
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26 · see citing works
Altered Reward Circuitry in the Norepinephrine Transporter Knockout Mouse
Gallagher, J. J., Zhang, X., Hall, F. S., Uhl, G. R., Bearer, E. L., & Jacobs, R. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057597 · Cited by 25 · see citing works
Hiraide, S., Ueno, K.-I., Yamaguchi, T., Matsumoto, M., Yanagawa, Y., Yoshioka, M., & Togashi, H. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.009 · Cited by 24 · see citing works
Pan, N., Ma, T., Liu, Y., Zhang, S., Hu, S., Shekara, A., Cao, H., Gong, Q., & Chen, Y. (2024) · Psychological Medicine · doi:10.1017/s003329172400285x · Cited by 7 · see citing works
“…non-stimulants may improve the top-down guidance of attention, thought and working memory in those with ADHD via direct effects on NET in the prefrontal cortex (Borchert et al., 2019; Bymaster et al., 2002; Lin & Gau, 2015; Mechler et al., 2022; Morón, Brockington, Wise, Rocha, & Hope, 2002).”
- Authors
- Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-01-15
- Volume
- 22
- Issue
- 2
- Pages
- 389-395
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6758674
- OpenAlex
- W1493305388
- Cited by
- 681
- References
- 50
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 36 · 2023: 16 · 2022: 22 · 2021: 18 · 2020: 26 · 2019: 20 · 2018: 29 · 2017: 20 · 2016: 30 · 2015: 30 · 2014: 35 · 2013: 36 · 2012: 26
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- dopamine uptake, norepinephrine transporter, dopamine transporter, cocaine, nisoxetine, GBR 12909, monoamine transporters, frontal cortex, caudate nucleus, nucleus accumbens, synaptosomes, dopamine clearance
- MeSH terms
- Animals, Brain, Brain Chemistry, Caudate Nucleus, Cocaine, Dopamine, Dose-Response Relationship, Drug, Fluoxetine, Frontal Lobe, Membrane Glycoproteins, Nerve Tissue Proteins, Norepinephrine, Nucleus Accumbens, Piperazines, Synaptosomes, Mice, Knockout, Dopamine Uptake Inhibitors, Membrane Transport Proteins, Symporters, Dopamine Plasma Membrane Transport Proteins, Norepinephrine Plasma Membrane Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review